Pantoprazole 20 mg on demand is effective in the long-term management of patients with mild gastro-oesophageal reflux disease

European Journal of Gastroenterology and Hepatology

Volumn 17, Issue 9, 2005, Pages 935-941

  Kaspari, Suleiman ^a   Kupcinskas, Limas ^b   Heinze, Hartmut ^c   Berghöfer, Peter ^c  

^a Kaunas Medical University ^*

^b KAUNAS UNIVERSITY OF MEDICINE   (Lithuania)

^c ALTANA PHARMA AG   (Germany)

Author keywords

Drug administration schedule; Follow up studies; Gastrooesophageal reflux drug therapy; Heartburn; Long term care; Treatment outcome

Indexed keywords

ANTACID AGENT; PANTOPRAZOLE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DYSPHAGIA; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LONG TERM CARE; MALE; MULTICENTER STUDY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; AGED; ANTHROPOMETRY; ANTI-ULCER AGENTS; BENZIMIDAZOLES; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; H(+)-K(+)-EXCHANGING ATPASE; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; OMEPRAZOLE; PATIENT DROPOUTS; RECURRENCE; SULFOXIDES; TREATMENT OUTCOME;

EID: 23944433411     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200509000-00009     Document Type: Article

References (26)

1. Dent J, Brun J, Fendrick AM, Fennerty MB, Janssens J, Kahrilas PJ, et al. On behalf of the Genval Workshop Group. An evidence-based appraisal of reflux disease management - The Genval Workshop Report. Gut 1999; 44(suppl 2):S1-S16.
2. Klinkenberg-Knol EC, Festen HP, Meuwissen SG. Pharmacological management of gastro-oesophageal reflux disease. Drugs 1995; 49: 695-710.
3. Bardhan KD. Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003; 98 (suppl 3):S40-S48.
4. Metz DC, Bochenek WJ. Pantoprazole US GORD Study Group. Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis. Aliment Pharmacol Ther 2003; 17:155-164.
5. Pilotto A, Franceschi M, Leandro G, Novello R, Di Mario F, Valerio G. Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up. Am J Ther 2002; 9:295-300.
6. Plein K, Hotz J, Wurzer H, Fumagalli I, Lühmann R, Schneider A. Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 2000; 12:425-432.
7. Escourrou J, Deprez P, Saggioro A, Geldorf H, Fischer R, Maier C. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis. Aliment Pharmacol Ther 1999; 13:1481-1491.
8. Van Rensburg CJ, Honiball PJ, Van Zyl JH, Grundling HD, Eloff FP, Spies SK, et al. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis - a 2-year follow-up. Aliment Pharmacol Ther 1999; 13:1023-1028.
9. Mössner J, Koop H, Porst H, Wübbolding H, Schneider A, Maier C. One-year prophylactic efficacy and safety of pantoprazole in controlling gastroesophageal reflux symptoms in patients with healed reflux disease. Aliment Pharmacol Ther 1997; 11:1087-1092.
10. Venables TL, Newland RD, Patel AC, Hole J, Copeman MB, Turbitt ML. Maintenance treatment for gastro-esophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol 1997; 32:627-632.
11. Lind T, Havelund T, Lundell L, Glise H, Lauritsen K, Pedersen S, et al. On demand therapy with omeprazole for the long-term management of patients with heartburn without oesophagitis - a placebo-controlled randomized trial. Aliment Pharmacol Ther 1999; 13:907-914.
12. Cibor DA, Ciecko-Michalska I, Szczepanek M, Bogdal J. Optimal maintaining therapy in patients with non-erosive reflux disease. Gut 2004; 53 (suppl VI):A117.
13. Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Mourn B, Bang C, et al. Esomeprazole 20 mg maintains symptom control in endoscopy-negative gastro-esophageal reflux disease: a controlled trial of 'on-demand' therapy for 6 months. Aliment Pharmacol Ther 2001; 15:347-354.
14. Talley NJ, Venables TL, Green JR, Armstrong D, O'Kaine KP, Giaffer M, et al. Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-esophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months. Eur J Gastroenterol Hepatol 2002; 14:857-863.
15. Kao AW, Sheu BS, Sheu MJ, Chang YM, Huang SF, Chuang CH, et al. On-demand therapy for Los Angeles grade A and B reflux esophagitis: esomeprazole versus omeprazole. J Formos Med Assoc 2003; 102: 607-612.
16. Tsai HH, Chapman R, Shepherd A, McKeith D, Anderson M, Vearer D, et al. Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND study. Aliment Pharmacol Ther 2004; 20:657-665.
17. Johnsson F, Moum B, Vilien M, Grove O, Simren M, Thoring M. On-demand treatment in patients with oesophagitis and reflux symptoms: comparison of lansoprazole and omeprazole. Scand J Gastroenterol 2002; 37: 642-647.
18. Cooper AL, Baxter G. Efficacy of lansoprazole on demand therapy in the treatment of non-erosive reflux disease and functional ulcer-like dyspepsia. Gut 2003; 52 (suppl 6):A137.
19. Hassani Z, Vrijens B, Bigard M. Efficacy and safety of lansoprazole 15 mg on demand therapy of GORD. Gut 2004; 53 (suppl VI):A102.
20. Bytzer P, Slum A, De Herdt D, Dubois D. On behalf of the trial investigators. Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease. Aliment Pharmacol Ther 2004; 20:181-188.
21. Ivashkin VT, Trukhmanov AS, Maev IV. On-demand long-term management of patients suffering from non-erosive GORD with rabeprazole 10mg. Gut 2004; 53 (suppl VI):A101.
22. Schölten T, Gatz G, Sander P. On-demand therapy with pantoprazole 20 mg o.d. for the long-term management of GORD patients previously healed from heartburn [Abstract]. Gut 2001; 49 (suppl III):A64.
23. Tytgat GN. Management of mild and severe gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2003; 17 (suppl 2):52-56.
24. Savary M, Miller G. Das Oesophagus-Lehrbuch und endoskopischer Atlas. Soluthurn: Gassmann; 1977.
25. Siewert JR, Ottenjann R, Heilmann K, Neiss A, Döpfer H. Therapy and prevention of reflux esophagitis. Results of a multicenter study with cimetidine. I: Epidemiology and results of acute therapy. Zeitschrift Gastroenterol 1986; 24:381-395.
26. Van Berge Henegouwen MT, van Driel HF, Kasteleijn-Nolst Tenite DG. A patient diary to improve medicine compliance. Pharm World Sci 1999; 21:21-24.